These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6977702)

  • 1. Heterogeneity of human T-cell growth factor(s) due to variable glycosylation.
    Robb RJ; Smith KA
    Mol Immunol; 1981 Dec; 18(12):1087-94. PubMed ID: 6977702
    [No Abstract]   [Full Text] [Related]  

  • 2. T-cell growth factor and the culture of cloned functional T cells.
    Smith KA; Ruscetti FW
    Adv Immunol; 1981; 31():137-75. PubMed ID: 6172026
    [No Abstract]   [Full Text] [Related]  

  • 3. Human T-cell growth factor: purification biochemical characterization, and interaction with a cellular receptor.
    Robb RJ
    Immunobiology; 1982 Mar; 161(1-2):21-50. PubMed ID: 7047366
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular characterization of interleukin 2 produced from tumor cell lines and T cell hybridomas.
    Gillis S; Mochizuki D
    Curr Top Microbiol Immunol; 1982; 100():211-9. PubMed ID: 6980094
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential bioassay of interleukin 2 and interleukin 4.
    Ho SN; Abraham RT; Gillis S; McKean DJ
    J Immunol Methods; 1987 Apr; 98(1):99-104. PubMed ID: 3494085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of interleukin 2.
    Gillis S; Mochizuki DY; Conlon PJ; Hefeneider SH; Ramthun CA; Gillis AE; Frank MB; Henney CS; Watson JD
    Immunol Rev; 1982; 63():167-209. PubMed ID: 7042544
    [No Abstract]   [Full Text] [Related]  

  • 7. Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity.
    Welte K; Wang CY; Mertelsmann R; Venuta S; Feldman SP; Moore MA
    J Exp Med; 1982 Aug; 156(2):454-64. PubMed ID: 6980256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and biologic characterization of lymphocyte regulatory molecules. VIII. Purification of interleukin 2 from a human T cell leukemia.
    Frank MB; Watson J; Mochizuki D; Gillis S
    J Immunol; 1981 Dec; 127(6):2361-5. PubMed ID: 6975318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of monoclonal B cell growth factor (BCGF) produced by a human T-T hybridoma.
    Butler JL; Ambrus JL; Fauci AS
    J Immunol; 1984 Jul; 133(1):251-5. PubMed ID: 6427336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of a B cell activation factor (BCAF) produced by a human T cell line.
    Bowen DL; Ambrus JL; Fauci AS
    J Immunol; 1986 Mar; 136(6):2158-63. PubMed ID: 3485143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comitogenic serum glycoprotein in T lymphocyte activation.
    Fabricius HA; Köttgen E; Stahn R; Löhr GW
    Immunobiology; 1982 Dec; 163(5):436-49. PubMed ID: 6984416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A T cell clone which responds to interleukin 2 but not to interleukin 4.
    Müller W; Vandenabeele P
    Eur J Immunol; 1987 Apr; 17(4):579-80. PubMed ID: 3494619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A biochemical variant of human T cell growth factor produced by a cutaneous T cell lymphoma cell line.
    Gootenberg JE; Ruscetti FW; Gallo RC
    J Immunol; 1982 Oct; 129(4):1499-505. PubMed ID: 6980938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A T cell-derived factor stimulating multipotential hemopoietic stem cells: molecular weight and distinction from T cell growth factor and T cell-derived granulocyte-macrophage colony-stimulating factor.
    Schrader JW; Clark-Lewis I
    J Immunol; 1982 Jul; 129(1):30-5. PubMed ID: 6979567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and partial characterization of human intracellular B cell growth factor.
    Sahasrabuddhe CG; Martin B; Maizel AL
    Lymphokine Res; 1986; 5(2):127-40. PubMed ID: 3486330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phorbol myristate acetate and in vitro T lymphocyte function. I. PMA may contaminate lymphokine preparations and can interfere with interleukin bioassays.
    Orosz CG; Roopernian DC; Bach FH
    J Immunol; 1983 Apr; 130(4):1764-9. PubMed ID: 6403611
    [No Abstract]   [Full Text] [Related]  

  • 17. Chromatofocusing as a tool for the characterization and partial purification of human interleukin-2.
    Gérard JP; Bertoglio J
    J Immunol Methods; 1982 Dec; 55(2):243-51. PubMed ID: 6984451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial purification and biochemical characterization of a T cell suppressor factor produced by human glioblastoma cells.
    Schwyzer M; Fontana A
    J Immunol; 1985 Feb; 134(2):1003-9. PubMed ID: 3871205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of mouse interleukins.
    Henriksen O; Alvarez VL; Barnes M; Bächtold H; Frey JR; Hansson E; Howie S; Lefkovits I; Roitsch CA; Söderberg A; Young P
    FEBS Lett; 1980 Nov; 121(1):157-60. PubMed ID: 6780374
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical separation of interleukin 2.
    Mochizuki DY; Watson J; Gillis S
    J Immunol Methods; 1980; 39(3):185-201. PubMed ID: 6970230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.